223 related articles for article (PubMed ID: 12029623)
1. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation.
Pañeda C; Gorospe I; Herrera B; Nakamura T; Fabregat I; Varela-Nieto I
Hepatology; 2002 Jun; 35(6):1381-91. PubMed ID: 12029623
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.
Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Martín-Duce A; Fortes P; Caballería J; Avila MA; Mato JM
Gastroenterology; 2003 Apr; 124(4):940-8. PubMed ID: 12671891
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
5. S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver.
García-Trevijano ER; Latasa MU; Carretero MV; Berasain C; Mato JM; Avila MA
FASEB J; 2000 Dec; 14(15):2511-8. PubMed ID: 11099469
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
Yang H; Magilnick N; Noureddin M; Mato JM; Lu SC
J Cell Physiol; 2007 Mar; 210(3):766-73. PubMed ID: 17154373
[TBL] [Abstract][Full Text] [Related]
7. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate.
Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T
Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116
[TBL] [Abstract][Full Text] [Related]
8. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
9. The role of c-Myb in the up-regulation of methionine adenosyltransferase 2A expression in activated Jurkat cells.
Zeng Z; Yang H; Huang ZZ; Chen C; Wang J; Lu SC
Biochem J; 2001 Jan; 353(Pt 1):163-168. PubMed ID: 11115410
[TBL] [Abstract][Full Text] [Related]
10. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
Chen L; Zeng Y; Yang H; Lee TD; French SW; Corrales FJ; García-Trevijano ER; Avila MA; Mato JM; Lu SC
FASEB J; 2004 May; 18(7):914-6. PubMed ID: 15033934
[TBL] [Abstract][Full Text] [Related]
11. Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells.
Rodríguez JL; Boukaba A; Sandoval J; Georgieva EI; Latasa MU; García-Trevijano ER; Serviddio G; Nakamura T; Avila MA; Sastre J; Torres L; Mato JM; López-Rodas G
Int J Biochem Cell Biol; 2007; 39(4):842-50. PubMed ID: 17317269
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
Huang ZZ; Mato JM; Kanel G; Lu SC
Hepatology; 1999 May; 29(5):1471-8. PubMed ID: 10216131
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-met expression in rats with acute hepatic failure.
Mizuguchi T; Kamohara Y; Hui T; Neuman T; Mitaka T; Demetriou AA; Rozga J
J Surg Res; 2001 Aug; 99(2):385-96. PubMed ID: 11469916
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
16. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.
Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K
Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400
[TBL] [Abstract][Full Text] [Related]
19. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
20. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
